Envisia Therapeutics Investor
Envisia Therapeutics is a biotechnology company focused on the research and development of novel ocular therapies.
Founded Date:
2013-01-01
Last Funding Type:
Series A
Headquarters:
United States
Investors Number:
5
Technology:
Regenerative Medicine
Employee Number:
11-50
Industry:
Biotechnology, Health Care, Science and Engineering
Estimated Revenue:
$1M to $10M
Last Funding Date:
2016-03-17
Funding Status:
Early Stage Venture
Investor Type:
For Profit
Total Funding:
46100000 USD